Natalizumab (BG00002) Re-Initiation of Dosing. (STRATA) ClinicalTrials.gov, 4 Apr 2014 Accessed on 12 Jun 2014 from http://www.clinicaltrials.gov/ct2/show/NCT00297232. CommentRecommendBookmarkWatch